Company profile
Harvard Apparatus Regenerative Technology Inc.
OTC: HRGN · Healthcare · Biotechnology
PublicHQ Holliston, MACIK 0001563665Reports USD
#904 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
41DFH 28DQ 60GM —SS 45
v0.1 · 55/100 weight · provisional
↑ disclosure history, revenue growth (YoY) · ↓ return on equity, Altman-Z
Methodology →Revenue TTM
$859.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$6.9M
Employees
8
as of 2026-08-21
Market cap
$26.7M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$704.0k$704.0k2025
Net income-$6.9M-$6.9M2025
Operating income-$6.9M-$6.9M2025
Total assets$2.7M$2.7M2025
Liabilities$1.6M$1.6M2025
Equity$1.1M$1.1M2025
Revenue trend
FY2017 – FY2025 · USD
FY17
FY18
FY19
FY21
FY21
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Harvard Apparatus Regenerative Technology Inc.’s revenue?
Harvard Apparatus Regenerative Technology Inc. booked $704.0k in FY2025 revenue, growing 64% year over year — faster than most Healthcare companies we track, at a -975.7% net margin.
Peers · Healthcare
Relevium Technologies Inc.——Applied Biosciences Corp.——Lexaria Bioscience Corp.44DAdia Nutrition, Inc.29DUnicycive Therapeutics, Inc.32DSETO Holdings, Inc.54DKey facts
CEOJunli He
SectorHealthcare
IndustryBiotechnology
HeadquartersHolliston, MA
ExchangeOTC: HRGN
Employees8
IPO date2013-10-21
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.